Cell Types
This page provides lists of the cell types currently being used to create data at the LINCS centers. These tables will be updated as cell types are added.
Broad LINCS Cell Types
The cell types being used by the Broad LINCS team include:
| ID | Name | Status | Cell Type | Description | ATCC # | Growth Properties | Organ | Disease | Receptors |
|---|---|---|---|---|---|---|---|---|---|
| 1 | MCF7 | In production | Cancer cell line | Breast | HTB-22 | adherent | mammary gland; breast | adenocarcinoma | estrogen receptor, expressed |
| 2 | PC3 | In production | Cancer cell line | Prostate | CRL-1435 | adherent | prostate | adenocarcinoma | vitronectin |
| 3 | A549 | In production | Cancer cell line | Lung | CCL-185 | adherent | lung | NSCLC | |
| 4 | A375 | In production | Cancer cell line | Melanoma | CRL-1619 | adherent | skin | malignant melanoma | |
| 5 | HepG2 | In production | Cancer cell line | Liver carcinoma | HB-8065 | adherent | liver | hepatocellular carcinoma | insulin-like growth factor II (IGF II) |
| 6 | VCaP | In production | Cancer cell line | Prostate | CRL-2876 | ||||
| 7 | HCC515 | In production | Cancer cell line | Lung | adherent | lung | NSCLC | ||
| 8 | HT29 | In production | Cancer cell line | Colon | HTB-38 | adherent | colon | colorectal adenocarcinoma | human adrenergic alpha2A; urokinase receptor (u-PAR), vitamin D (moderate expression) |
| 9 | HA1E | In production | Immortalized normal | Kidney epithelial | |||||
| 10 | ASC* | Passed assay devt In lysate production |
Primary | adipocyte | |||||
| 11 | SKL* | Passed assay devt In lysate production |
Primary | skeletal myocyte (LONZA) | |||||
| 12 | PHH* | Passed assay devt In lysate production |
Primary | hepatocyte | adherent | ||||
| 13 | NPC* | Passed assay devt In lysate production |
Primary | iPS-derived neural progenitor | |||||
| 14 | NEU* | Passed assay devt In lysate production |
Primary | terminally differentiated neuron | |||||
| 15 | MAC* | In assay development | Primary | PBMC-derived macrophages | |||||
| 16 | HME1* | In assay development | Immortalized normal | mammary epithelium | CRL-4010 | ||||
| 17 | HF* | In assay development | Primary | fibroblast (epithelial) | reduction mammoplasty; normal hTERT immortalized |
*nominated by the scientific community
HMS LINCS Cell Types
Cell types profiled jointly by the Broad LINCS team and the HMS LINCS team include:
| Name | Description | ATCC # | Growth Properties | Organ | Disease | Receptors |
|---|---|---|---|---|---|---|
| MCF7 | Breast | HTB-22 | adherent | mammary gland; breast | adenocarcinoma | estrogen receptor, expressed |
| MCF10A | Breast | CRL-10317 | adherent | mammary gland; breast | fibrocystic disease | |
| SKBR3 | Breast | HTB-30 | adherent | mammary gland; breast | adenocarcinoma | |
| MDAMB231 | Breast | HTB-26 | adherent | mammary gland; breast | adenocarcinoma | epidermal growth factor (EGF), expressed; transforming growth factor alpha (TGF alpha), expressed |
| BT20 | Breast | HTB-19 | adherent | mammary gland; breast | carcinoma | epidermal growth factor (EGF), expressed; transforming growth factor alpha (TGF alpha), expressed |
Experimental Verification
The teams will mainly use genotypes obtained from SNP arrays for comparison to in CCLE and with the Sanger SNP60 CGP dataset, as well as a panel of 48 SNPs to fingerprint the cell types.
For more information on the guidance being used by the LINCS teams for experimental verification, see the following article: American Type Culture Collection Standards Development Organization Workgroup ASN-0002. Cell line misidentification: the beginning of the end. Nat Rev Cancer. 2010;10:441-448. Epub 2010 May 7.